作者: Alexandre Bozec , Marius Ilie , Paul Hofman
DOI: 10.1007/978-94-007-5842-1_12
关键词:
摘要: The development of molecular biology analyses in thyroid pathology is currently active and provides new diagnostic tools with the aim accurately distinguishing malignant benign tumors. This particularly useful as most these can be done preoperatively on fine-needle aspiration biopsy samples. Furthermore, biomarkers may have a promising role account their ability to predict prognosis Moreover, identification markers well better understanding carcinogenesis are attractive prospects for innovative targeted therapies, patients metastatic iodo-resistant carcinoma.